annual SGA:
$114.33M-$74.03M(-39.30%)Summary
- As of today (September 18, 2025), AMLX annual SGA is $114.33 million, with the most recent change of -$74.03 million (-39.30%) on December 31, 2024.
- During the last 3 years, AMLX annual SGA has risen by +$75.40 million (+193.66%).
- AMLX annual SGA is now -39.30% below its all-time high of $188.36 million, reached on December 31, 2023.
Performance
AMLX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$15.64M-$44.00K(-0.28%)Summary
- As of today (September 18, 2025), AMLX quarterly SGA is $15.64 million, with the most recent change of -$44.00 thousand (-0.28%) on June 1, 2025.
- Over the past year, AMLX quarterly SGA has dropped by -$6.01 million (-27.75%).
- AMLX quarterly SGA is now -72.92% below its all-time high of $57.76 million, reached on March 31, 2024.
Performance
AMLX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$2.50B-$187.60M(-8.10%)Summary
- As of today (September 18, 2025), AMLX TTM SGA is -$2.50 billion, with the most recent change of -$187.60 million (-8.10%) on June 1, 2025.
- Over the past year, AMLX TTM SGA has dropped by -$2.68 billion (-1487.45%).
- AMLX TTM SGA is now -3584.78% below its all-time high of -$67.91 million.
Performance
AMLX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AMLX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.3% | -27.8% | -1487.5% |
| 3 y3 years | +193.7% | -47.9% | -3611.5% |
| 5 y5 years | +3610.8% | +298.1% | -10000.0% |
AMLX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.3% | +193.7% | -72.9% | at low | -305.4% | at low |
| 5 y | 5-year | -39.3% | +3610.8% | -72.9% | +298.1% | -3584.8% | at low |
| alltime | all time | -39.3% | +3610.8% | -72.9% | +298.1% | -3584.8% | at low |
AMLX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $15.64M(-0.3%) | $66.25M(-8.3%) |
| Mar 2025 | - | $15.68M(-8.3%) | $72.26M(-36.8%) |
| Dec 2024 | $114.33M(-39.3%) | $17.10M(-4.1%) | $114.33M(-23.5%) |
| Sep 2024 | - | $17.83M(-17.6%) | $149.47M(-17.1%) |
| Jun 2024 | - | $21.65M(-62.5%) | $180.37M(-10.8%) |
| Mar 2024 | - | $57.76M(+10.6%) | $202.11M(+7.3%) |
| Dec 2023 | $188.36M | $52.24M(+7.2%) | $188.36M(+6.4%) |
| Sep 2023 | - | $48.72M(+12.3%) | $176.96M(+11.9%) |
| Jun 2023 | - | $43.39M(-1.4%) | $158.18M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $44.01M(+7.7%) | $144.78M(+13.9%) |
| Dec 2022 | $127.13M(+226.5%) | $40.84M(+36.4%) | $127.13M(+25.6%) |
| Sep 2022 | - | $29.94M(-0.2%) | $101.20M(+42.0%) |
| Jun 2022 | - | $29.99M(+13.8%) | $71.27M(+45.6%) |
| Mar 2022 | - | $26.35M(+76.6%) | $48.93M(+71.2%) |
| Dec 2021 | $38.93M(+158.5%) | $14.92M(+94.8%) | $28.58M(+62.5%) |
| Jun 2021 | - | $7.66M(+27.5%) | $17.59M(+77.1%) |
| Mar 2021 | - | $6.00M(+52.8%) | $9.93M(+152.8%) |
| Dec 2020 | $15.06M(+388.8%) | $3.93M | $3.93M |
| Dec 2019 | $3.08M | - | - |
FAQ
- What is Amylyx Pharmaceuticals, Inc. annual SGA?
- What is the all time high annual SGA for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. annual SGA year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. quarterly SGA year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. TTM SGA?
- What is the all time high TTM SGA for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. TTM SGA year-on-year change?
What is Amylyx Pharmaceuticals, Inc. annual SGA?
The current annual SGA of AMLX is $114.33M
What is the all time high annual SGA for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high annual SGA is $188.36M
What is Amylyx Pharmaceuticals, Inc. annual SGA year-on-year change?
Over the past year, AMLX annual SGA has changed by -$74.03M (-39.30%)
What is Amylyx Pharmaceuticals, Inc. quarterly SGA?
The current quarterly SGA of AMLX is $15.64M
What is the all time high quarterly SGA for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high quarterly SGA is $57.76M
What is Amylyx Pharmaceuticals, Inc. quarterly SGA year-on-year change?
Over the past year, AMLX quarterly SGA has changed by -$6.01M (-27.75%)
What is Amylyx Pharmaceuticals, Inc. TTM SGA?
The current TTM SGA of AMLX is -$2.50B
What is the all time high TTM SGA for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high TTM SGA is -$67.91M
What is Amylyx Pharmaceuticals, Inc. TTM SGA year-on-year change?
Over the past year, AMLX TTM SGA has changed by -$2.68B (-1487.45%)